We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+12.56%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
–
Cap. Flow
+$3.41B
Cap. Flow %
101.25%
Top 10 Hldgs %
50.48%
Holding
489
New
489
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$483M
2
NVDA icon
NVIDIA
NVDA
+$247M
3
AAPL icon
Apple
AAPL
+$186M
4
TSM icon
TSMC
TSM
+$179M
5
MSFT icon
Microsoft
MSFT
+$143M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 52.03%
2 Consumer Discretionary 19.21%
3 Communication Services 9.64%
4 Miscellaneous 4.78%
5 Healthcare 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
476
Allogene Therapeutics
ALLO
$701M
$86.6K ﹤0.01%
+35,492
New +$71.1K
PURR
477
Hyperliquid Strategies Inc
PURR
$2.68B
$85K ﹤0.01%
+16,691
New +$75.5K
VNDA icon
478
Vanda Pharmaceuticals
VNDA
$319M
$80.2K ﹤0.01%
+11,603
New +$89.5K
LXEO icon
479
Lexeo Therapeutics
LXEO
$393M
$72.8K ﹤0.01%
+12,683
New +$89.9K
VSTM icon
480
Verastem
VSTM
$657M
$72.7K ﹤0.01%
+13,717
New +$84.6K
ABUS icon
481
Arbutus Biopharma
ABUS
$1.02B
$69.5K ﹤0.01%
+15,443
New +$67.5K
MYGN icon
482
Myriad Genetics
MYGN
$301M
$66.2K ﹤0.01%
+14,709
New +$76.6K
OCGN icon
483
Ocugen
OCGN
$458M
$64.4K ﹤0.01%
+35,562
New +$61.5K
RCKT icon
484
Rocket Pharmaceuticals
RCKT
$406M
$63.5K ﹤0.01%
+17,751
New +$70.5K
MDXG icon
485
MiMedx Group
MDXG
$669M
$61.4K ﹤0.01%
+15,543
New +$78.3K
AKBA icon
486
Akebia Therapeutics
AKBA
$248M
$57.2K ﹤0.01%
+41,119
New +$56.5K
AVXL icon
487
Anavex Life Sciences
AVXL
$282M
$55.5K ﹤0.01%
+18,070
New +$78.3K
IVVD icon
488
Invivyd
IVVD
$283M
$50.1K ﹤0.01%
+38,502
New +$70.7K
CATX icon
489
Perspective Therapeutics
CATX
$354M
$48.7K ﹤0.01%
+11,667
New +$49.3K
16 17 18 19
20

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, E Fund Management held 489 positions worth $3.37B. Its ten largest holdings account for 50% of the portfolio.

E Fund Management deployed $3.41B of net new capital in Q1 2026, opening 489 new positions. Its largest new stake was Pinduoduo: 4,593,053 shares worth $469M.

By sector, the portfolio is most concentrated in Technology at 52% of assets, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q1 2026 buy was Pinduoduo: 4,593,053 shares worth $469M.
  • E Fund Management's ten largest holdings make up 50% of its $3.37B portfolio in Q1 2026.
  • E Fund Management opened 489 new positions and closed 0 in Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.